Royalty Pharma plc (RPRX)

NASDAQ: RPRX · Real-Time Price · USD

58.44

+0.03 (0.05%)

At close: Sep 21, 2026, 4:00 PM EDT

58.38

-0.06 (-0.10%)

After-hours: Sep 21, 2026, 5:22 PM EDT

Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	33,603	16,509	11,334	12,497	17,432	17,116
Market Cap Growth	61.68%	45.66%	-9.30%	-28.31%	1.85%	-11.89%
Enterprise Value	41,728	27,726	21,332	21,132	27,333	26,687
Last Close Price	58.44	38.12	24.55	26.21	35.95	35.60

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	31.35	21.41	13.20	11.01	407.00	27.62
Forward PE	10.57	7.70	6.10	7.47	10.32	13.00
PS Ratio	13.25	6.94	5.01	5.31	7.79	7.48
PB Ratio	3.81	1.70	1.10	1.24	1.83	1.67
P/TBV Ratio	5.69	2.97	1.63	1.92	3.11	2.97
P/OCF Ratio	11.29	6.63	4.09	4.18	8.13	8.48
PEG Ratio	1.32	0.79	2.14	2.65	0.94	1.12

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	16.45	11.66	9.42	8.98	12.22	11.66
EV/EBITDA Ratio	26.79	17.74	-	14.11	29.44	18.36
EV/EBIT Ratio	26.88	17.78	16.51	14.16	29.62	18.65

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.92	0.92	0.74	0.61	0.75	0.69
Debt / EBITDA Ratio	5.75	5.74	-	4.10	7.66	4.88
Net Debt / Equity Ratio	0.83	0.86	0.64	0.56	0.56	0.48
Net Debt / EBITDA Ratio	5.22	5.33	-	3.77	5.79	3.38
Asset Turnover	0.13	0.13	0.13	0.14	0.13	0.14
Quick Ratio	2.79	2.39	1.43	7.78	2.11	16.77
Current Ratio	2.80	2.40	1.44	7.90	2.19	16.81
Return on Equity (ROE)	13.96%	13.20%	13.03%	17.34%	2.33%	12.32%
Return on Assets (ROA)	5.09%	5.15%	4.67%	5.62%	3.36%	5.33%
Return on Capital Employed (ROCE)	8.10%	8.20%	7.60%	9.20%	5.90%	8.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.42%	4.67%	7.58%	9.08%	0.25%	3.62%
Dividend Yield	1.61%	2.31%	3.42%	3.05%	2.11%	1.91%
Payout Ratio	50.42%	49.06%	43.83%	31.57%	778.21%	46.02%
Buyback Yield / Dilution	3.88%	4.99%	1.46%	-37.66%	-5.59%	-10.48%
Total Shareholder Return	5.49%	7.30%	4.88%	-34.61%	-3.47%	-8.57%

SEC Filings: 10-K · 10-Q